Table 2 Demographic data of the patients
From: A retrospective study regarding the influence of COVID-19 disease on asthma
Parameter | Controlled asthma (n = 73) | Uncontrolled asthma (n = 90) | p |
|---|---|---|---|
Age | 21.05 ± 10.2 | 29.59 ± 19.7 | 0.6 |
Sex | |||
Male | 61.6% (45) | 30% (27) | 0.01 |
Female | 38.4% (28) | 70% (63) | 0.01 |
Living area | |||
Urban | 78.2% (62) | 68.4% (69) | 0.7 |
Rural | 21.8% (11) | 31.6% (21) | 0.8 |
Asthma duration (months) | 128 ± 96.8 | 296 ± 59.7 | 0.05 |
Rhinitis present | 80.8% (59) | 77.7% (70) | 0.9 |
Asthma scores | |||
ACT | 22 ± 2 | 13 ± 5 | 0.01 |
VAS | 8 ± 2 | 3 ± 4 | 0.01 |
Asthma GINA steps treatment | |||
Step 1 | 9.6% (7) | 36.6% (33) | 0.05 |
Step 2 | 19.2% (14) | 12.2% (11) | 0.8 |
Step 3 | 34.2% (25) | 6.8% (6) | 0.04 |
Step 4 | 27.4% (20) | 21.1% (19) | 0.9 |
Step 5 | 5.6% (4) | 23.3% (21) | 0.03 |
COVID 19 infection | |||
No present | 79.5% (58) | 75.5% (68) | 0.9 |
Present | 21.5% (15) | 24.5% (22) | 0.6 |